Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 2862
Selected: 0
NCT IDTitle
NCT05088889Maintenance Ipilimumab + Nivolumab Post Induction Chemotherapy + SBRT for First Line Treatment Stage IV Pancreatic Cancer
NCT03936374A Study to Evaluate the Effect of Omeprazole on the Pharmacokinetics of BMS-986205 in Healthy Participants
NCT03812562Nivolumab and Yttrium-90 in Treating Patients With Liver Cancer Undergoing Surgical Resection
NCT02758769Long-Term Outcomes With Abatacept In Biologic Treatment-Naive Rheumatoid Arthritis Patients In Japanese Clinical Practice Settings
NCT03195491A Study of Non-Small Cell Lung Cancer (NSCLC) Patients Receiving Second-Line Nivolumab Monotherapy in Asia
NCT00176605Phase II Metronomic Dosing, Etoposide, Cyclophosphamide, D0 Prostate Cancer
NCT01750580Safety Study of BMS-986015 (Anti-KIR) in Combination With Ipilimumab in Subjects With Selected Advanced Tumor
NCT00135369Switching HIV-1 Infected Subjects From a Highly Active Anti-Retroviral Treatment (HAART) Regimen Dosed Twice Daily or More Frequently to a Once-Daily Regimen
NCT04289259Tumor Mutational Burden in Lung Cancer Patients
NCT00918879Evaluate Saxagliptin in Adult Indian Patients With Type 2 Diabetes Inadequate Glycemic Control
NCT03059888Trial of Orencia in Patients With Myasthenia Gravis
NCT00095394Irbesartan/Hydrochlorothiazide (HCTZ) Combination Therapy as First Line Treatment for Severe Hypertension
NCT04263051Evaluation of UCPVax Plus Nivolumab as Second Line Therapy in Advanced Non Small Cell Lung Cancer
NCT05136677A Study to Evaluate Nivolumab in Combination With Ipilimumab Versus Pemetrexed With Cisplatin or Carboplatin for Unresectable Pleural Mesothelioma in Chinese Participants
NCT04230330Nivolumab in Combination With GDP/ L-asparaginase in NK/ T-cell Lymphoma
NCT05543629A Study of BMS-986442 With Nivolumab With or Without Chemotherapy in Solid Tumors and Non-small Cell Lung Cancer
NCT03430791Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma
NCT00886782A Study of BMS-863233 in Patients With Advanced and/or Metastatic Solid Tumors
NCT01024062Phase II Study of Weekly Paclitaxel (BMS-181339) in Patient With Non-Small Cell Lung Cancer (NSCLC)
NCT01340586Pharmacokinetics and Pharmacodynamics of Apixaban in Subjects on Hemodialysis
NCT00250705Trial of Aripiprazole in the Treatment of CD in Adolescents
NCT06710470A Study on the Safety of Deucravacitinib Exposure in Pregnant Women and Their Offspring
NCT00096746Effect of the Atazanavir (ATV) 150L Mutation on Subsequent Treatment Response in HIV Infected Subjects
NCT03355482MRI Evaluation Assessing Synovitis to Address the Unmet Need for Reliable Endpoints in SLE
NCT00597259Pegasys Plus Entecavir Versus Entecavir Alone for Hepatitis Be Antigen-Positive Chronic Hepatitis B
NCT04825873A Study to Assess Safety of Nivolumab in Routine Oncology Practice in China
NCT00371150Effect of Entecavir in Blacks/African Americans and Hispanics With Chronic Hepatitis B Virus (HBV) Infection
NCT01155427Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)
NCT01193361Ph IIA Study (SOC +/- NS5B)
NCT04463368Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases
NCT03438279Survival Study for Participants Treated With Ipilimumab-Nivolumab Combination Therapy
NCT00949988A Study of Dasatinib and Rituximab for Relapsed/Refractory Chronic Lymphocytic Leukemia
NCT00000772A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals
NCT07465029A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain
NCT01018745Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in Japan
NCT00655746The Effect of Omeprazole on the Pharmacokinetics of Dasatinib in Healthy Subjects
NCT01279954Abatacept in the Treatment of Uveitis
NCT00326131A Phase I Study of a Single Dose of Radio-labeled BMS-275183 in Patients With Advanced Cancer
NCT05678283A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors
NCT00420186A Phase I Study of BMS-690514 in Combination With Paclitaxel and Carboplatin
NCT00732186Study of Ipilimumab and Dasatinib Combination Therapy in Patients With Chronic or Accelerated Chronic Myeloid Leukemia
NCT00706641Neoadjuvant Dasatinib and Radical Cystectomy for Transitional Cell Carcinoma of the Bladder
NCT03150303Oral Anticoagulant Peri-procedural Management in Patients Undergoing an Oral Surgery, Implantology or Periodontology
NCT04311710A Study Evaluating the Drug Levels of Iplimumab Given Under the Skin Alone and in Combination With Nivolumab in Multiple Tumor Types
NCT03215927Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease
NCT01359644Study to Determine the Safety and Effectiveness of Antiviral Combination Therapy to Treat Hepatitis C Virus (HCV) in Patients Who Have Previously Not Received the Standard of Care
NCT01393964Study of Elotuzumab in Combination With Lenalidomide and Dexamethasone in Subjects With Multiple Myeloma and Various Levels of Renal Function
NCT03114163Observational Study of Nivolumab in Participants in Germany With Squamous Cell Carcinoma of the Head and Neck (SCCHN) Progressing on or After Platinum-Based Therapy
NCT02967133A Study of Nivolumab +/- Nab-paclitaxel in Non-small Cell Lung Cancer
NCT01585987An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy